| Patent | Date |
|---|
Tyrosine analogues derivatives as Rho-kinase inhibitors
Grant 11,147,812 - Accetta , et al. October 19, 2 | 2021-10-19 |
Tyrosine Amide Derivatives As Rho- Kinase Inhibitors
App 20210284639 - ACCETTA; Alessandro ; et al. | 2021-09-16 |
Tyrosine amide derivatives as Rho-Kinase inhibitors
Grant 10,954,236 - Accetta , et al. March 23, 2 | 2021-03-23 |
Tyrosine Analogues Derivatives As Rho-kinase Inhibitors
App 20210023080 - ACCETTA; Alessandro ; et al. | 2021-01-28 |
Meta Tyrosine Derivatives As Rho-kinase Inhibitors
App 20200377500 - ACCETTA; Alessandro ; et al. | 2020-12-03 |
Tyrosine Amide Derivatives As Rho- Kinase Inhibitors
App 20200079774 - ACCETTA; Alessandro ; et al. | 2020-03-12 |
Bicyclic dihydropyrimidine-carboxamide derivatives as Rho-Kinase inhibitors
Grant 10,584,128 - Accetta , et al. | 2020-03-10 |
Tyrosine amide derivatives as Rho-kinase inhibitors
Grant 10,501,461 - Accetta , et al. Dec | 2019-12-10 |
Tyrosine Amide Derivatives As Rho- Kinase Inhibitors
App 20180215758 - Accetta; Alessandro ; et al. | 2018-08-02 |
Bicyclic Dihydropyrimidine-carboxamide Derivatives As Rho- Kinase Inhibitors
App 20180170939 - Accetta; Alessandro ; et al. | 2018-06-21 |
Pyrazine Derivatives As Enac Blockers
App 20170143705 - BHALAY; Gurdip ; et al. | 2017-05-25 |
Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
Grant 9,643,983 - Bhalay , et al. May 9, 2 | 2017-05-09 |
Pyrazine derivatives as ENaC blockers
Grant 9,522,149 - Bhalay , et al. December 20, 2 | 2016-12-20 |
Treating Diseases Mediated By Blockade Of The Epithelial Sodium Channel With Pyrazine-2-carboxamide Derivatives
App 20160068546 - BHALAY; Gurdip ; et al. | 2016-03-10 |
Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
Grant 9,139,586 - Bhalay , et al. September 22, 2 | 2015-09-22 |
Pyrazine Derivatives As Enac Blockers
App 20150224098 - BHALAY; Gurdip ; et al. | 2015-08-13 |
Pyrazine derivatives as ENaC blockers
Grant 9,050,339 - Bhalay , et al. June 9, 2 | 2015-06-09 |
IP receptor agonist heterocyclic compounds
App 20140357641 - Bhalay; Gurdip ; et al. | 2014-12-04 |
Treating Diseases Mediated By Blockade Of The Epithelial Sodium Channel With Pyrazine-2-carboxamide Derivatives
App 20140171421 - Bhalay; Gurdip ; et al. | 2014-06-19 |
Pyrazine Derivatives As Enac Blockers
App 20140113914 - BHALAY; Gurdip ; et al. | 2014-04-24 |
Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
Grant 8,697,687 - Bhalay , et al. April 15, 2 | 2014-04-15 |
3-Spirocyclic Piperidine Derivatives as Ghrelin Receptor Agonists
App 20130331369 - Ambarkhane; Ameet Vijay ; et al. | 2013-12-12 |
3-spirocyclic piperidine derivatives as ghrelin receptor agonists
Grant 8,546,416 - Ambarkhane , et al. October 1, 2 | 2013-10-01 |
Pyrazine derivatives as enac blockers
Grant 8,372,845 - Bhalay , et al. February 12, 2 | 2013-02-12 |
Organic Compounds
App 20130012500 - BHALAY; Gurdip ; et al. | 2013-01-10 |
3-spirocyclic Piperidine Derivatives As Ghrelin Receptor Agonists
App 20120302540 - Ambarkhane; Ameet Vijay ; et al. | 2012-11-29 |
Quinuclidine derivatives binding to mucarinic M3 receptors
Grant 8,168,654 - Collingwood , et al. May 1, 2 | 2012-05-01 |
Pyrazine Derivatives As Enac Blockers
App 20120071479 - Bhalay; Gurdip ; et al. | 2012-03-22 |
Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel
Grant 8,039,472 - Bhalay , et al. October 18, 2 | 2011-10-18 |
Pyrrolidine derivatives acting as CCR3-receptor antagonists
Grant 7,754,758 - Bhalay , et al. July 13, 2 | 2010-07-13 |
Organic Compounds
App 20100130506 - BHALAY; Gurdip ; et al. | 2010-05-27 |
Quinuclidine Derivatives Binding To Mucarinic M3 Receptors
App 20100041887 - Collingwood; Stephen Paul ; et al. | 2010-02-18 |
Pyrrolidine Derivatives Acting As Ccr3-receptor Antagonists
App 20090306138 - Bhalay; Gurdip ; et al. | 2009-12-10 |
Trisubstituted Quinazolinone Derivatives as Vanilloid Antagonists
App 20090082365 - Bhalay; Gurdip ; et al. | 2009-03-26 |
Organic Compunds
App 20080096943 - Bhalay; Gurdip ; et al. | 2008-04-24 |
8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
Grant 7,361,661 - Bhalay , et al. April 22, 2 | 2008-04-22 |
Derivatives of 3-phenyl-n-(2-(4-benzyl)-piperidin-1-yl)-ethyl)-acrylamid with ccr-3-receptor antagonistic activity for use in the treatment of inflammations and allergic conditions
Grant 7,259,173 - Bhalay , et al. August 21, 2 | 2007-08-21 |
Quinuclidine derivatives binding to mucarinic m3 receptors
App 20070060563 - Collingwood; Stephen Paul ; et al. | 2007-03-15 |
8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
App 20060173181 - Bhalay; Gurdip ; et al. | 2006-08-03 |
8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
App 20060106214 - Bhalay; Gurdip ; et al. | 2006-05-18 |
8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
Grant 7,019,136 - Bhalay , et al. March 28, 2 | 2006-03-28 |
8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
Grant 6,919,337 - Bhalay , et al. July 19, 2 | 2005-07-19 |
8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
App 20050054660 - Bhalay, Gurdip ; et al. | 2005-03-10 |
N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists
App 20040087621 - Bhalay, Gurdip ; et al. | 2004-05-06 |
8-Quinolinxanthine and 8-isoquinolinxant hine derivatives as PDE 5 inhibitors
App 20040038996 - Bhalay, Gurdip ; et al. | 2004-02-26 |
Piperidine compounds for use as ccr-3 inhibitors
Grant 6,670,379 - Howe , et al. December 30, 2 | 2003-12-30 |
Piperidine compounds for use as ccr-3 inhibitors
App 20030176460 - Howe, Trevor John ; et al. | 2003-09-18 |
8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
App 20030171384 - Bhalay, Gurdip ; et al. | 2003-09-11 |
| 